Limbach Holdings (LMB) Tops Q3 EPS by 23c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus
Go back to Limbach Holdings (LMB) Tops Q3 EPS by 23c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 50.05 -2.51 (4.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.56 | 52 Week High | $0.15 | |||
| Open | $54.00 | 52 Week Low | $0.15 | |||
| Day High | $54.39 | P/E | N/A | |||
| Day Low | $48.89 | EPS | $0.00 | |||
| Volume | 318,475 | |||||
